by nms-sync | Oct 1, 2022 | News
Accelera Srl Announces Change in Board Composition Effective Today
Nerviano_October_1_2022_Accelera Srl, leading CRO and a member of the NMS Group today announced the change in its Board Composition, following the resignation of its board member Enrico...
by nms-sync | Jun 29, 2022 | News
The Board of Directors of NMS Group S.p.A has approved today the company’s annual financial report, including the consolidated financial statements of the Group as of 31 December 2021.
“2021 was a challenging yet rewarding year for our Group. As we firmly believe...
by nms-sync | May 5, 2022 | News
Nerviano, 5 May 2022
NMS Group SpA today announced that its CEO, Hugues Dolgos, has accepted the resignation of Angelo Colombo as CEO of Accelera Srl and NerPharMa Srl, effective 31 May 2022. Hugues Dolgos will act as interim CEO for both companies. A...
by nms-sync | Feb 7, 2022 | News
Nerviano, 7 February 2022
NMS Group, the center of excellence of oncology research and development in the heart of the Lombardy region is honored to receive the visit by Ms. Isabella Tovaglieri, Member of the European Parliament, Mr. Emanuele Monti, Chairman of...
by nms-sync | Jan 17, 2022 | News
Nerviano, 17 January 2022
The Shareholders’ Meeting of NMS Group S.p.A. (the “Company”) has appointed new Board of Directors for a three-year term. Tak-Wai (David) Wong has been named Chairman of the Board. Other newly appointed board members are...
Welcome and Check out our new motion picture!
Recent Comments